trial
as of 2026-07-01A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia
NCTId NCT05646264
at a glance
Phase 4 · Unknown
Enrollment 220 (estimated)
Sponsored by Shanghai Mental Health Center
Primary completion 2023-08-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Unknown
Enrollment
220 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2023-01-01
Primary completion
2023-08-01
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Shanghai Mental Health CenterLead Sponsor
Tianjin Anding HospitalCollaborator
Investigators
1
yizhenghui1971@163.com Yi, M.DPrincipal Investigator
Sites
1 total
Shanghai, China
Facts & assertions
4 sourced
Enrollment
220
Phase
PHASE4
Primary Completion Date
2023-08-01
Status
UNKNOWN
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
company
indication
investigator